| Dr Jonathan Scott Collins, MD | |
|
10810 Connecticut Ave, Kensington, MD 20895-2138 | |
| (301) 929-7161 | |
| (301) 929-7024 |
| Full Name | Dr Jonathan Scott Collins |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 41 Years |
| Location | 10810 Connecticut Ave, Kensington, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669467411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101048905 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578638425 PECOS PAC ID: 3779495858 Enrollment ID: O20040805001280 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1073678637 PECOS PAC ID: 3779495858 Enrollment ID: O20100729000796 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Scott Collins, MD 2489 Iron Forge Rd, Herndon, VA 20171-2917 Ph: (703) 742-7472 | Dr Jonathan Scott Collins, MD 10810 Connecticut Ave, Kensington, MD 20895-2138 Ph: (301) 929-7161 |
News Archive
Researchers from the Franciscan University of Steubenville, Ohio are exploring a possible link between metabolic defects and seizures. They determined that diet could influence susceptibility to seizures, and they have identified a common diabetes drug that could be useful in treating disorders such as epilepsy.
Tucked into the federal budget law Congress passed in February was a provision that significantly expands the use of telemedicine — long a hyped health care reform, and now poised to go mainstream within five to 10 years.
In Canada, 26% of infections are resistant to the medicines that are generally first prescribed to treat an infection, a rate that could rise to 40% or beyond in the coming decades, according to an expert panel convened by the Council of Canadian Academies. By 2050, a total of 396,000 lives could be lost and the Canadian economy could lose $388 billion per year.
This post in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog is the first of a series in which Research!America, a member of the GHTC, will profile various U.S. states based on an analyses the organization conducted "to measure the economic impact of [research & development (R&D)], highlighting the benefits of it for states across the nation," and to examine "what the [U.S.] is doing to advance global health R&D and why our continued support of such work is crucial for the health and prosperity of our future."
› Verified 4 days ago
Dr. Tim B. Hopkins, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Department Of Ophthalmology, Kensington, MD 20895 Phone: 301-929-7354 Fax: 301-929-7024 | |
Dr. Benjamin D Magno, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Fritz M Joseph Allen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Dr. Amy Min-chi Siris, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kaiser Permanente Kensington Medical Center, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Rohit K Bhatnagar, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7354 Fax: 301-929-7024 |